RADIOPHARM THERANOSTICS LTD (RADX) Stock Income Statement
USA - NASDAQ:RADX - ADR
5.275 USD
-0.05 (-1.03%)
5.4971 USD
+0.22 (+4.21%)
| 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.63M | 299.20K | 292.40K | 0.00 | 0.00 | |||
| Minority Interest Expense | 1.64M | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 3.59M | N/A | N/A | N/A | N/A | |||
| Gross Profit | 39.30K | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 33.79M | 37.42M | 34.52M | 19.92M | 484.80K | |||
| Research and Development | 24.93M | 19.97M | 22.03M | 4.51M | N/A | |||
| Selling, General, and Administrative Expenses | 16.53M | 15.67M | 15.26M | 12.44M | 484.80K | |||
| Operating Income | -33.75M | -37.12M | -34.23M | -19.92M | -484.80K | |||
| Interest Income/Expense | -4.49M | -10.73M | -343.30K | -10.46M | N/A | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -400.00 | |||
| Income Before Taxes | -38.24M | -47.85M | -34.57M | -30.38M | -485.20K | |||
| Income Tax | 103.30K | 96.40K | 38.00K | 44.40K | 0.00 | |||
| Net Income | -36.70M | -47.95M | -34.61M | -30.42M | -485.20K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.28 | -37.25 | -32.08 | -45.98 | -0.57 | |||
| Statistics | ||||||||
| Gross Profit Margin | 1.08% | N/A | N/A | N/A | N/A | |||
| Profit Margin | -1010.16% | -16025.77% | -11836.94% | N/A | N/A | |||
| Operating Profit Margin | -928.95% | -12407.55% | -11706.53% | N/A | N/A | |||
All data in AUD